Biofarm S.A.

BIO

Biofarm S.A. manufactures and sells medicines in Romania.The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and an...

Website | Pharmaceutical Preparations | Health Care

Automated Financial Analysis

🤵

Financial Advisor Insight

"Technicals confirm a positive long-term trend, supported by moving averages."

Sentiment: Neutral Action: Hold

"Company demonstrates strong financial health with positive growth and stability indicators."

High Profitability (Net Margin: 25.9%).

Bullish Trend (SMA50 > SMA200).

Price above upper Bollinger Band (potential reversal).

Stochastic indicates overbought conditions.

Forecast: Continued Revenue Growth (~9.7% next year).

Technical Analysis

Trend Bullish (Long Term)

Last Cross

Golden Cross (1 year ago)

RSI (14) 70.0

SMA 50 1.37

SMA 200 1.26

Price Valuation

Current Price 1.37

Fair Value (PE 15) 1.13

Overvalued 17%

Graham Number 0.91

Downside 34%

Forecast

Rev Forecast (Next Yr) 314M

Growth Forecast 9.7%

📊 Market & Peer Context

Benchmark: BET

Volatility (Beta)

-0.16

Less Volatile than Market

Correlation

-0.08

Moves with Market

Relative Strength (1Y)

-12.03%

vs Benchmark

Index Returns (1Y)

47.5%

BET

Historical Performance

Metric	5Y	3Y	1Y	YTD	6M	3M	1M	1W
BIO	118.2%	74.3%	69.6%	69.1%	10.5%	0.4%	0.0%	0.0%
BET	-	124.9%	47.5%	30.0%	13.9%	-6.8%	-8.6%	0.2%
Alpha (Diff)	-	-50.6%	+22.0%	+39.1%	-3.4%	+7.2%	+8.6%	-0.2%

Financial Reports

Price Chart

Volume Bollinger Bands SMA 50 SMA 200 RSI (14) MACD

Evoluție Istorică (Fundamente)

Cum au evoluat metricile cheie an de an - ca să vezi dacă BIO crește, stagnează sau se deteriorează, nu doar cum arată azi.

Indicator	2021	2022	2023	2024	2025	2026 TTM	2026 TTM	Tendință
P/E Ratio ⓘ	13.62	8.56	10.54	9.46	7.93	14.52	19.13	▼ +5.51
ROE ⓘ	19.33%	19.90%	18.91%	16.30%	19.61%	18.48%	17.55%	▼ -1.78%
Randament Dividend ⓘ	3.82%	6.23%	4.61%	5.11%	5.89%	13.55%	3.07%	▼ -0.76%
Datorie / Capital Propriu ⓘ	—	—	0.00	0.00	0.00	0.00	0.00	▼ +0.00

Precizie Prognoză (Istoric)

Cât de aproape au fost estimările trecute de creștere/valoare justă față de ce s-a întâmplat de fapt.

Colectăm date din 15.08.2026 - prima comparație va fi posibilă din 2025, când apare raportul anual real pentru acel an.

Sector: Health Care

Based on Market Cap

ETAPA 1 • MUST HAVE

6/8

Healthy Leverage (Debt/Equity) ⓘ

0.00 țintă < 1.5

▲

Gross Margin vs Industry ⓘ

83.6% vs 54.1% țintă > 54.1%

▲

Operating Cash Flow vs Profit ⓘ

77% țintă > 100%

▲

Free Cash Flow vs Profit ⓘ

46% țintă > 80%

▲

ROIC (Return on Capital) ⓘ

10.69% țintă Positive

▼

ROIC vs WACC ⓘ

ROIC: 10.7% / WACC: 3.0% țintă > WACC

▼

ROE (Return on Equity) ⓘ

16.3% țintă > 10%

▼

EBITDA Positive ⓘ

95.26M țintă > 0

▲

ETAPA 2 • CRITERII

11/12

Interest Coverage ⓘ

N/A țintă > 3x

▲

N/A

Net Margin vs Industry ⓘ

25.9% țintă > 9.1%

▲

Passed

ROA vs Industry ⓘ

9.3% țintă > 4.6%

▼

Passed

Current Ratio ⓘ

4.34 țintă > 1.5

▲

Passed

Assets Growth (5y) ⓘ

10.5% CAGR țintă > 0%

▲

Passed

FCF CAGR (5y) ⓘ

29.9% țintă > 5%

▲

Passed

EV/EBITDA vs Industry ⓘ

6.2 vs 9.9 țintă < Industry

▲

Passed

Net Debt / EBITDA ⓘ

0.01 țintă < 3

▲

Passed

Revenue CAGR (5y) ⓘ

7.3% țintă > 5%

▲

Passed

Quick Ratio ⓘ

3.60 țintă > 1.0

▲

Passed

Payout Ratio (Dividend) ⓘ

39.2% țintă < 80%

▼

Passed

EBITDA Margin vs Industry ⓘ

33.2% vs 17.5% țintă > 17.5%

▼

Passed

SNAPSHOT COMPANIE

BUY 84% încredere

Etapa 1: 75% • Etapa 2: 100%

Semnal algoritmic bazat pe fundamentale, nu recomandare de investiție.

Capitalizare ⓘ

1.35B RON

EBITDA ⓘ

95.26M

P/E Ratio ⓘ

18.15

PEG Ratio ⓘ

2.49

Dividend Yield ⓘ

4.50%

Beta ⓘ

-0.16

Valoare Intrinsecă (Graham) vs. Preț Curent ⓘ

Preț Curent 1.37 RON

Valoare Graham 0.91 RON

Supraevaluare 33.7%

financial report

Annual Data

Metric	TTM	TTM	2025	2024	2023
Fiscal Year	2,026	2,026	2,025	2,024	2,023
Fiscal Quarter	Q2	Q1	Q4	Q4	Q4
Marketcap	1,349,953,097	1,320,392,080	798,147,451	703,552,198	811,942,593
Enterprise Value	1,143,068,506	1,090,018,590	613,400,621	588,404,077	698,647,192
Last Close Ratios	137.00%	134.00%	71.29%	60.62%	67.27%
Pe	19.13	14.52	7.93	9.46	10.54
Forward PE	-	-	11.26	11.26	11.26
PS Ratio	4.59	4.17	2.50	2.45	2.90
PB Ratio	3.42	2.27	1.46	1.47	1.87
P/TBV Ratio	3.44	2.28	1.46	1.48	1.87
P/FCF Ratio	25.47	17.54	12.12	20.59	16.24
P/OCF Ratio	19.00	14.27	9.91	12.22	10.17
Evrevenue	3.88	3.44	1.92	2.05	2.49
EV/EBITDA Ratio	12.77	9.47	5.35	6.20	7.42
EV/EBIT Ratio	16.75	11.45	6.38	7.56	9.04
EV/FCF Ratio	21.57	14.48	9.31	17.22	13.98
Debtequity	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.01	0.01	0.01	0.01	0.01
Debt / FCF Ratio	0.02	0.02	0.02	0.03	0.02
Net Debt / Equity Ratio	-0.52	-0.40	-0.31	-0.26	-0.26
Net Debt / EBITDA Ratio	-2.31	-2.00	-1.48	-1.29	-1.18
Net Debt / FCF Ratio	-3.90	-3.06	-2.57	-3.59	-2.22
Asset Turnover	49.30%	50.00%	53.60%	54.70%	58.40%
Inventory Turnover	66.70%	87.40%	83.70%	84.90%	87.20%
Quick Ratio	1.53	4.22	3.92	3.61	3.67
Current Ratio	1.90	4.93	4.95	4.34	4.70
Roe	17.55%	18.48%	19.61%	16.30%	18.91%
Return on Assets (ROA)	7.14%	9.40%	10.08%	9.28%	10.06%
Return on Invested Capital (ROIC)	22.35%	22.78%	22.90%	20.18%	22.89%
Return on Capital Employed (ROCE)	0.17	0.16	0.18	0.16	0.18
Earningsyield	5.80%	7.64%	12.61%	10.57%	9.49%
FCF Yield	3.93%	5.70%	8.25%	4.86%	6.16%
Dividend Yield	3.07%	13.55%	5.89%	5.11%	4.61%
Payout Ratio	87.48%	28.99%	29.05%	39.24%	36.67%
Buyback Yield / Dilution	-0.75%	-0.75%	-0.75%	-0.40%	-0.83%
Totalreturn	2.32%	12.80%	5.14%	4.71%	3.78%

Balance Sheet

Annual Data

Metric	TTM	2024	2023	2022	2021
Fiscal Year	2,025	2,024	2,023	2,022	2,021
Fiscal Quarter	Q3	Q4	Q4	Q4	Q4
Cash & Equivalents	155,759,338	61,843,963	20,660,190	82,713,880	103,865,018
Short-Term Investments	30,000,000	62,000,000	91,000,000	-	-
Totalcash	185,759,338	123,843,963	111,660,190	82,713,880	103,865,018
Cash Growth	60.07%	10.91%	35.00%	-20.36%	37.49%
Accounts Receivable	145,900,549	129,956,492	86,165,730	117,664,030	95,636,855
Other Receivables	14,885,251	18,556,970	16,973,969	14,948,696	10,704,180
Receivables	160,785,800	148,513,462	103,139,699	132,612,726	106,341,035
Inventory	42,770,207	53,171,622	57,953,909	56,654,482	29,328,344
Prepaid Expenses	-	-	-	-	-
Other Current Assets	3,464,280	2,947,244	2,395,806	1,999,018	613,242
Assetsc	392,779,625	328,476,291	275,149,604	273,980,106	240,147,639
Property, Plant & Equipment	196,233,052	199,170,107	193,716,330	170,930,851	159,267,486
Other Intangible Assets	1,489,298	1,218,765	771,809	63,958	220,808
Other Long-Term Assets	12,824,062	12,786,795	12,170,748	11,789,958	11,697,338
Assets	615,771,434	555,481,351	493,813,612	466,536,087	418,778,898
Accounts Payable	36,402,011	47,587,826	35,166,895	46,417,359	40,765,119
Accrued Expenses	26,291,186	15,473,853	12,818,031	12,910,567	10,612,005
Current Income Taxes Payable	4,944,534	1,842,002	2,389,082	1,974,462	-
Current Unearned Revenue	-	1,130,308	21,261	15,953,773	21,408,834
Other Current Liabilities	11,811,287	9,602,770	8,107,867	8,389,234	12,557,300
Total Current Liabilities	79,449,018	75,636,759	58,503,136	85,645,395	85,343,258
Long-Term Debt	1,012,510	1,012,510	899,350	-	-
Long-Term Deferred Tax Liabilities	-	-	-	-	-
Other Long-Term Liabilities	531,719	570,625	-	-	-
Total Liabilities	80,993,247	77,219,894	59,402,486	86,480,516	85,991,581
Common Stock	98,537,535	98,537,535	98,537,535	98,537,535	98,537,535
Retained Earnings	422,149,264	365,632,534	321,782,203	274,330,564	227,062,310
Comprehensive Income & Other	14,265,355	14,265,355	14,265,355	7,361,439	7,361,439
Equity	534,778,187	478,261,457	434,411,126	380,055,571	332,787,317
Total Liabilities & Equity	615,771,434	555,481,351	493,813,612	466,536,087	418,778,898
Filing Date Shares Outstanding	985,367,224	985,367,224	985,367,224	985,367,224	985,367,224
Total Common Shares Outstanding	985,367,224	985,367,224	985,367,224	985,367,224	985,367,224
Book Value Per Share	0.54	0.49	0.44	0.39	0.34
Tangible Book Value	533,288,889	477,042,692	433,639,317	379,991,613	332,566,509
Tangible Book Value Per Share	0.54	0.48	0.44	0.39	0.34
Total Debt	1,012,510	1,012,510	899,350	-	-
Net Cash (Debt)	184,746,828	122,831,453	110,760,840	82,713,880	103,865,018
Net Cash Growth	60.44%	10.90%	33.91%	-20.36%	37.49%
Netcashpershare	0.17	0.11	0.10	0.08	0.10
Working Capital	313,330,607	252,839,532	216,646,468	188,334,711	154,804,381
Treasury Stock	-173,967	-173,967	-173,967	-173,967	-173,967
Land	12,593,537	12,593,537	10,924,113	7,993,073	7,993,073
Buildings	66,688,791	66,665,648	64,975,381	73,261,701	73,261,701
Machinery	224,853,825	177,502,224	155,097,199	150,815,950	137,731,753
Construction In Progress	10,394,659	49,851,463	55,217,861	36,382,234	25,793,085
Pension & Post-Retirement Benefits	-	-	-	835,121	648,323
Long-Term Deferred Tax Assets	12,445,397	13,829,393	12,005,121	9,771,214	7,445,627

Cash Flow Statement

Annual Data

Metric	TTM	2024	2023	2022	2021
Fiscal Year	2,025	2,024	2,023	2,022	2,021
Fiscal Quarter	Q3	Q4	Q4	Q4	Q4
Net Income	88,206,223	74,396,967	77,012,898	70,917,262	60,355,769
Depreciation & Amortization	17,403,724	17,027,781	16,959,885	15,500,531	13,729,158
Loss (Gain) From Sale of Assets	-426,997	-163,713	-308,624	-50,924	-212,029
Loss (Gain) From Sale of Investments	-	-	-	-	-
Asset Writedown & Restructuring Costs	-134,692	-134,692	-2,782,712	-1,924,908	-387,953
Provision & Write-off of Bad Debts	-	-	-1,724,474	-55,887	-
Change in Accounts Receivable	-7,613,266	-46,370,880	30,800,713	-24,576,400	-3,303,557
Change in Inventory	2,125,073	2,223,310	-1,651,289	-29,763,086	3,433,018
Change in Other Net Operating Assets	12,384,762	13,173,436	-27,428,032	1,788,206	-874,665
Other Operating Activities	-7,967,292	-2,561,428	-11,050,683	-2,817,498	-3,557,820
Ncfo	103,977,535	57,590,781	79,827,682	29,017,296	69,181,921
Ocf Growth	68.17%	-27.86%	175.10%	-58.06%	75.10%
Capex	-14,093,417	-23,414,590	-29,842,137	-30,129,569	-21,450,501
Investment in Securities	40,000,000	29,000,000	-91,000,000	-	21,000,000
Other Investing Activities	8,596,623	7,030,873	6,881,772	2,457,773	877,502
Ncfi	34,930,202	12,784,717	-113,641,838	-27,620,872	827,496
Long-Term Debt Repaid	-	-	-	-	-
Net Debt Issued (Repaid)	-	-	-	-	-
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-29,195,864	-29,191,725	-28,239,534	-22,547,562	-20,687,983
Financing Cash Flow	-29,195,864	-29,191,725	-28,239,534	-22,547,562	-20,687,983
Net Cash Flow	109,711,873	41,183,773	-62,053,690	-21,151,138	49,321,434
Free Cash Flow	89,884,118	34,176,191	49,985,545	-1,112,273	47,731,420
Free Cash Flow Growth	268.41%	-31.63%	-	-	297.13%
Fcf Margin	28.19%	11.92%	17.83%	-0.40%	19.97%
Fcfps	0.08	0.03	0.05	0.00	0.05
Levered Free Cash Flow	69,389,267	18,498,973	36,033,450	-21,115,212	40,472,203
Unlevered Free Cash Flow	69,389,267	18,498,973	36,033,452	-21,115,156	40,472,205
Cash Interest Paid	-	-	-	-	2
Cash Income Tax Paid	15,827,587	11,509,027	9,250,952	14,633,228	13,744,813
Change Working Capital	6,896,569	-30,974,134	1,721,392	-52,551,280	-745,204
Sale of Property, Plant & Equipment	426,996	168,434	318,527	50,924	400,495

Income Statement

Annual Data

Metric	TTM	2024	2023	2022	2021
Fiscal Year	2,025	2,024	2,023	2,022	2,021
Fiscal Quarter	Q3	Q4	Q4	Q4	Q4
Revenue	318,891,171	286,771,613	280,288,775	276,982,692	239,044,656
Revenue Growth	12.93%	2.31%	1.19%	15.87%	10.45%
Operating Revenue	318,891,171	286,771,613	280,288,775	276,982,692	239,044,656
Other Revenue	-	-	-	-	-
Cost of Revenue	50,899,703	47,151,065	49,977,248	45,694,737	40,444,407
Gp	267,991,468	239,620,548	230,311,527	231,287,955	198,600,249
Selling, General & Admin	118,281,283	108,597,898	109,680,563	105,689,340	90,132,477
Amortization of Goodwill & Intangibles	-	-	-	-	13,316,839
Other Operating Expenses	38,635,181	35,897,444	28,862,728	33,137,623	26,285,861
Operating Expenses	174,146,590	161,388,431	153,061,686	154,175,395	129,735,177
Operating Income	93,844,878	78,232,117	77,249,841	77,112,560	68,865,072
Interest Expense	-	-	-2	-89	-3
Interest & Investment Income	7,974,123	6,408,373	6,881,775	3,138,361	877,503
Currency Exchange Gain (Loss)	-782,468	-	-156,898	-	-
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT Excluding Unusual Items	101,036,533	84,640,490	83,974,716	80,250,832	69,742,572
Gain (Loss) on Sale of Assets	-1,390	-4,721	-9,903	-	-188,466
Gain (Loss) on Sale of Investments	-	-	-	-	-
Asset Writedown	-	-	-	1,841,383	-
Pretax Income	100,890,886	84,527,400	83,711,318	80,880,310	69,554,106
Income Tax Expense	12,684,663	10,130,433	6,698,420	9,963,048	9,198,337
Net Income	88,206,223	74,396,967	77,012,898	70,917,262	60,355,769
Net Income to Common	88,206,223	74,396,967	77,012,898	70,917,262	60,355,769
Net Income Growth	9.82%	-3.40%	8.60%	17.50%	11.23%
Shares Basic	985,367,224	985,367,224	985,367,224	985,367,224	985,367,224
Shares Outstanding (Diluted)	1,084,503,892	1,084,503,892	1,080,124,796	1,071,257,734	1,060,580,886
Shares Yo Y	0.00	0.00	0.01	0.01	0.00
Eps Basic	0.09	0.08	0.08	0.07	0.06
EPS (Diluted)	0.08	0.07	0.07	0.07	0.06
EPS Growth	9.38%	-3.79%	7.70%	16.35%	10.92%
Free Cash Flow	89,884,118	34,176,191	49,985,545	-1,112,273	47,731,420
Free Cash Flow Per Share	0.08	0.03	0.05	0.00	0.05
Dps	0.03	0.03	0.03	0.03	0.02
Dividend Growth	-	-	3.33%	25.00%	9.09%
Gross Margin	84.04%	83.56%	82.17%	83.50%	83.08%
Operating Margin	29.43%	27.28%	27.56%	27.84%	28.81%
Profit Margin	27.66%	25.94%	27.48%	25.60%	25.25%
Free Cash Flow Margin	28.19%	11.92%	17.83%	-0.40%	19.97%
Effective Tax Rate	0.13	0.12	0.08	0.12	0.13
EBITDA	111,248,602	95,259,898	94,209,726	92,613,091	82,594,230
D&A For EBITDA	17,403,724	17,027,781	16,959,885	15,500,531	13,729,158
EBITDA Margin	34.89%	33.22%	33.61%	33.44%	34.55%
EBIT	93,844,878	78,232,117	77,249,841	77,112,560	68,865,072
EBIT Margin	29.43%	27.28%	27.56%	27.84%	28.81%
Legal Settlements	-144,257	-108,369	-253,495	-1,211,905	-
Advertising Expenses	-	56,684,678	56,873,015	57,892,367	48,379,416
Payoutratio	33.10%	39.24%	36.67%	31.79%	34.28%

Ratios and Metrics

Annual Data

Metric	TTM	2024	2023	2022	2021
Fiscal Year	2,025	2,024	2,023	2,022	2,021
Fiscal Quarter	Q3	Q4	Q4	Q4	Q4
Marketcap	811,942,593	703,552,198	811,942,593	606,986,210	821,796,265
Market Cap Growth	9.87%	-13.35%	33.77%	-26.14%	94.86%
Enterprise Value	627,195,762	588,404,077	698,647,192	496,303,579	702,962,134
Last Close Ratios	82.40%	68.88%	76.43%	54.71%	71.32%
Pe	10.13	9.46	10.54	8.56	13.62
Forward PE	-	11.26	11.26	11.26	11.26
PS Ratio	2.55	2.45	2.90	2.19	3.44
PB Ratio	1.52	1.47	1.87	1.60	2.47
P/TBV Ratio	1.52	1.48	1.87	1.60	2.47
P/FCF Ratio	9.03	20.59	16.24	-	17.22
P/OCF Ratio	7.81	12.22	10.17	20.92	11.88
EV/Sales Ratio	1.97	2.05	2.49	1.79	2.94
EV/EBITDA Ratio	5.64	6.18	7.42	5.36	8.51
EV/EBIT Ratio	6.68	7.52	9.04	6.44	10.21
EV/FCF Ratio	6.98	17.22	13.98	-	14.73
Debt / Equity Ratio	0.00	0.00	0.00	-	-
Debt / EBITDA Ratio	0.01	0.01	0.01	-	-
Debt / FCF Ratio	0.01	0.03	0.02	-	-
Asset Turnover	54.90%	54.70%	58.40%	62.60%	60.40%
Inventory Turnover	113.50%	84.90%	87.20%	106.30%	128.00%
Quick Ratio	4.36	3.60	3.67	2.51	2.46
Current Ratio	4.94	4.34	4.70	3.20	2.81
Roe	17.43%	16.30%	18.91%	19.90%	19.33%
Return on Assets (ROA)	10.09%	9.32%	10.06%	10.89%	10.88%
Return on Capital (ROIC)	11.57%	10.69%	11.84%	13.52%	13.79%
Return on Capital Employed (ROCE)	0.18	0.16	0.18	0.20	0.21
Earningsyield	10.86%	10.57%	9.49%	11.68%	7.34%
FCF Yield	11.07%	4.86%	6.16%	-0.18%	5.81%
Dividend Yield	3.76%	4.50%	4.06%	5.48%	3.36%
Payout Ratio	33.10%	39.24%	36.67%	31.79%	34.28%
Buyback Yield / Dilution	-0.41%	-0.40%	-0.83%	-1.01%	-0.34%
Totalreturn	3.36%	4.10%	3.23%	4.48%	3.02%

Price History

Jun 21, 2019 — Aug 24, 2026 1825 Records

Date	Open	High	Low	Close	Volume
2026-08-24	1.36	1.37	1.36	1.37	208,309
2026-08-23	1.36	1.37	1.36	1.36	104,288
2026-08-20	1.37	1.37	1.36	1.36	171,878
2026-08-19	1.34	1.34	1.33	1.33	2,421
2026-08-18	1.34	1.34	1.33	1.34	28,101
2026-08-17	1.33	1.34	1.33	1.34	61,549
2026-08-16	1.34	1.34	1.33	1.33	20,629
2026-08-13	1.33	1.34	1.33	1.34	11,239
2026-08-12	1.34	1.34	1.33	1.33	14,774
2026-08-11	1.33	1.34	1.33	1.34	17,397
2026-08-10	1.33	1.34	1.32	1.33	126,659
2026-08-09	1.32	1.33	1.32	1.33	49,640
2026-08-06	1.33	1.33	1.33	1.33	28,526
2026-08-05	1.33	1.33	1.33	1.33	21,865
2026-08-04	1.33	1.34	1.33	1.33	58,968
2026-08-03	1.33	1.34	1.33	1.33	79,789
2026-08-02	1.34	1.34	1.33	1.34	5,148
2026-07-30	1.33	1.34	1.33	1.33	197,024
2026-07-29	1.34	1.35	1.33	1.33	6,348
2026-07-28	1.34	1.34	1.33	1.34	36,531
2026-07-27	1.35	1.35	1.33	1.33	56,380
2026-07-26	1.35	1.35	1.33	1.35	31,963
2026-07-23	1.34	1.35	1.31	1.35	127,453
2026-07-22	1.32	1.36	1.31	1.35	67,106
2026-07-21	1.33	1.38	1.31	1.37	180,624
2026-07-20	1.30	1.34	1.29	1.33	241,014
2026-07-19	1.37	1.37	1.28	1.31	129,290
2026-07-16	1.37	1.37	1.34	1.37	40,073
2026-07-15	1.36	1.37	1.34	1.34	20,342
2026-07-14	1.37	1.37	1.34	1.34	25,916
2026-07-13	1.37	1.37	1.37	1.37	120,710
2026-07-12	1.36	1.37	1.36	1.37	192,386
2026-07-10	1.36	1.37	1.36	1.37	190,747
2026-07-09	1.36	1.37	1.35	1.37	90,894
2026-07-08	1.37	1.37	1.36	1.37	128,426
2026-07-07	1.37	1.37	1.36	1.36	30,904
2026-07-06	1.36	1.37	1.35	1.37	288,624
2026-07-05	1.37	1.37	1.36	1.37	31,013
2026-07-03	1.37	1.37	1.36	1.37	31,013
2026-07-02	1.37	1.37	1.36	1.37	415,254
2026-07-01	1.36	1.37	1.36	1.37	200,936
2026-06-30	1.36	1.37	1.36	1.37	357,821
2026-06-29	1.38	1.38	1.36	1.38	379,492
2026-06-28	1.50	1.50	1.49	1.50	470,779
2026-06-26	1.50	1.50	1.49	1.50	470,779
2026-06-25	1.49	1.50	1.49	1.50	342,804
2026-06-24	1.49	1.49	1.48	1.48	148,724
2026-06-23	1.48	1.50	1.48	1.49	399,516
2026-06-22	1.48	1.48	1.48	1.48	227,558
2026-06-21	1.48	1.48	1.46	1.48	200,171